Gig Worker Benefits Platform Stride Health Announces $47 Million In New Funding
As the gig economy takes off, fueled in part by the pandemic, Stride Health, a benefits platform designed specifically for independent workers, announced that it has raised $47 million. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 26, 2021 Category: Pharmaceuticals Authors: Deb Gordon, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Source Type: news

Y Combinator Names Surbhi Sarna Its First-Ever Partner For Healthcare And Biotech
Subhi Sarna sold nVision Medical for $275 million in 2018. Now she's been named Y Combinator's first-ever group partner focused on healthcare and biotech as part of a pandemic-fueled deeper focus from the startup accelerator. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 26, 2021 Category: Pharmaceuticals Authors: Alex Konrad, Forbes Staff Tags: Venture Capital /venture-capital Innovation /innovation Healthcare /healthcare Science /science Leadership /leadership ForbesWomen /forbeswomen Entrepreneurs /entrepreneurs Editors' Pick editors-pick technology Source Type: news

These are the 20 highest-valued startups in Greater Philadelphia
Greater Philadelphia startups have been raking in cash over the last two years, and they have the valuations to prove it. Philadelphia-area companies have already raised a record amount of venture capital in 2021 with a total of $5.2 billion in funding as of Sept. 30, according to the latest Pitchbook-NVCA Venture Monitor report. Local startups snagged $1.8 billion across 91 deals in the third quarter alone. Philade lphia delivery startup Gopuff remains a VC juggernaut, raising another $1 billion… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 21, 2021 Category: Biotechnology Authors: Kennedy Rose Source Type: news

These Two Founders In Recovery Raised $118 Million For Their Virtual Addiction Treatment Startup
WorkIt Health cofounders Robin McIntosh and Lisa McLaughlin want to help the 9 in 10 Americans with a substance use disorder who have avoided treatment due to access or affordability or stigma. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 21, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Leadership /leadership ForbesWomen /forbeswomen Editors' Pick editors-pick Source Type: news

Brad Smith joins CareBridge Health as executive chairman
CareBridge was formed early last year by a group of former Aspire executives, including former U.S. Senate Majority Leader Bill Frist, with the help of a $40 million round of funding led by Greenwich, Connecticut-based venture capital firm Oak HC/FT. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 20, 2021 Category: Pharmaceuticals Authors: Joel Stinnett Source Type: news

Venture investment in 2021 on track for big year
Venture capital investors have pumped almost $1 billion into companies in the Portland metro area so far this year, surpassing the entire amount invested in companies last year. According to the latest data from Pitchbook and the National Venture Capital Association, there was $322.8 million invested in the third quarter of this year into 33 deals. That brings the total invested so far this year to $969.4 million in 115 deals in the Portland metro, according to the latest Venture Monitor report.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 14, 2021 Category: Pharmaceuticals Authors: Malia Spencer Source Type: news

Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
NEW BRUNSWICK, N.J. (October 12, 2021) – Johnson & Johnson (NYSE: JNJ) today announced that Paul Stoffels M.D., currently Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson, will retire from the Company effective December 31, 2021.As the Vice Chairman of the Executive Committee and Chief Scientific Officer, Dr. Stoffels spearheaded the company’s research and product pipeline leading teams across sectors to set the company-wide mandate to discover and develop transformational healthcare solutions. Under his leadership, Johnson & Johnson revitalized its innovati...
Source: Johnson and Johnson - October 12, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Meet The Sudanese Doctor Who Turned Nurse Staffing On Its Head
By helping hundreds of hospitals like HCA Healthcare hire nurses faster and with less aggravation, Iman Abuzeid has built the rare VC-backed startup that ’s already profitable. It likely won’t be long before it becomes a unicorn. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 12, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Business /business Venture Capital /venture-capital Entrepreneurs /entrepreneurs Small Business /small-business Daily Cover daily-cover Editors' Pick editors-pick Source Type: news

Early 20s The ‘Perfect Time’ For Women To Become Entrepreneurs, Says Spring Health’s April Koh, Youngest Female Unicorn CEO
Though Spring Health CEO Koh says the going as a super-young founder hasn ’t always been super easy—especially as a woman and a person of color—she also believes that inexperience has its advantages. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 11, 2021 Category: Pharmaceuticals Authors: Nina Wolpow, Forbes Staff Tags: Innovation /innovation Business /business Retail /retail Venture Capital /venture-capital Science /science Healthcare /healthcare Enterprise Tech /enterprise-tech Consumer Tech /consumer-tech Cloud /cloud Leadership / Source Type: news

RA Capital wraps third fund at $880M
Venture capital firm RA Capital Management has raised an $880 million fund, its third pool of capital for investment in biotech and pharmaceutical companies. The Boston-based firm says it will use a multi-stage approach, including new company formation, public equity and traditional venture financing — although RA Capital did not specify what stages it plans to target. This fund in particular will go largely toward investments in private companies. “As a multistage fund, we have the ability… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - October 8, 2021 Category: Health Management Authors: Rowan Walrath Source Type: news

RA Capital wraps third fund at $880M
Venture capital firm RA Capital Management has raised an $880 million fund, its third pool of capital for investment in biotech and pharmaceutical companies. The Boston-based firm says it will use a multi-stage approach, including new company formation, public equity and traditional venture financing — although RA Capital did not specify what stages it plans to target. This fund in particular will go largely toward investments in private companies. “As a multistage fund, we have the ability… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 8, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news

AffyImmune Therapeutics Announces $30M Series A+ Financing from ORI Capital
NATICK, Mass., Oct. 7, 2021 -- (Healthcare Sales & Marketing Network) -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company developing and deploying its Tune & Track platform for the use of CAR T cells to treat solid tumors, announced t... Biopharmaceuticals, Venture Capital AffyImmune Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 7, 2021 Category: Pharmaceuticals Source Type: news

Psychiatric drug startup launches with $500M, Amgen partnership
For the last two years, Neumora Therapeutics Inc. has been operating in stealth mode, quietly amassing a treasure trove of venture capital. Now that it's well past the point of scientific validation, Neumora is ready to make its public debut. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 7, 2021 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news

CoreBone Raises $3.7 Million Investment to Commercialize its Bioactive Bone Graft Material for Dental and Orthopedic Treatments and Expand Activity in China
TEL AVIV, Israel, Oct. 4, 2021 -- (Healthcare Sales & Marketing Network) -- CoreBone, a company that produces bioactive, coral-based bone graft material, announced that it has completed an investment round of $3.7 million. The Guangzhou Sino-Israel Biotec... Devices, Orthopaedic, Dental, Venture Capital CoreBone, bioactive bone graft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 4, 2021 Category: Pharmaceuticals Source Type: news

Artificial Intelligence Myth Vs Reality: Where Do Healthcare Experts Think We Stand?
“I think of it as a maturation process,” says Dr. John Halamka . “You’re asking why your three-year-old isn’t doing calculus. But can your three-year-old add a column of numbers? That’s actually not so bad.” (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 30, 2021 Category: Pharmaceuticals Authors: Seth Joseph, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Source Type: news

Open Stent Solution closes €2.5M Seed financing round for its breakthrough open-stent TMVR device
AMIENS, France, Sept. 28, 2021 -- (Healthcare Sales & Marketing Network) -- Open Stent Solution (OSS), a medtech start-up company developing the first open-stent heart valves, today announced the closing of a €2.5 million Seed financing round. The funding... Devices, Interventional, Cardiology, Venture Capital Open Stent Solution, open-stent heart valves, OSS valve, mitral valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 28, 2021 Category: Pharmaceuticals Source Type: news

Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders
Funding to rapidly advance Delix's novel non-hallucinatory, take-home, neuroplasticity-promoting candidates into clinical trials to better treat mental illness and other brain disorders at scale BOSTON, Sept. 27, 2021 -- (Healthcare Sales & Marketing Ne... Biopharmaceuticals, Neurology, Venture Capital Delix Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 27, 2021 Category: Pharmaceuticals Source Type: news

Amid Covid-19 Delta Surge, Hospital-At-Home Programs Could Relieve Hospital Rationing
Overloaded with unvaccinated Covid-19 patients, many hospitals are out of room. Hospital-at-home programs may help ease pressure to ration hospital care. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 21, 2021 Category: Pharmaceuticals Authors: Deb Gordon, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Coronavirus Source Type: news

Cytrellis Biosystems Completes $50 Million Series C Financing
Investment Led by D1 Capital Partners Will Support the Company's Commercialization Efforts and R&D Investments WOBURN, Mass., Sept. 21, 2021 -- (Healthcare Sales & Marketing Network) -- Cytrellis, a medical technology company dedicated to the developme... Devices, Dermatology, Venture Capital Cytrellis Biosystems, ellacor System, Micro-Coring (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 21, 2021 Category: Pharmaceuticals Source Type: news

YSPH Alumni Spotlight: At the forefront of medical innovation
Travis Whitfill ’14 M.P.H. discusses how YSPH helped prepare him for his current roles in venture capital, biotech, and as a research scientist and scholar. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 16, 2021 Category: Universities & Medical Training Source Type: news

Lightstone Ventures' raises $375M for its largest fund yet
The Boston and Silicon Valley-based venture capital firm Lightstone Ventures has raised its third life sciences fund. Here's what it plans to do with the money. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 14, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news

This Startup Raised $100 Million To Turbocharge Women ’s Health
With Tia, Forbes Under 30 alums Carolyn Witte and Felicity Yost have combined software and clinics to target the most valuable customer in healthcare: women. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 14, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Leadership /leadership ForbesWomen /forbeswomen Under 30 /under30 Venture Capital /venture-capital Editors' Pick editors-pick Coronavirus Source Type: news

Mammoth Biosciences Raises $195 Million, Vaulting Its Crispr Tech To Unicorn Status
Investors are betting the protein toolbox of the four-year-old startup can solve one of gene therapy ’s trickiest problems: getting treatments into the patient’s body. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 9, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Science /science Venture Capital /venture-capital Editors' Pick editors-pick Coronavirus Source Type: news

Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
Funding to Advance Pipeline of Engineered TIL Therapies for Solid Tumors into Clinical Studies CAMBRIDGE, Mass., Sept. 9, 2021 -- (Healthcare Sales & Marketing Network) -- Obsidian Therapeutics, Inc., a biotechnology company pioneering engineered cell ... Biopharmaceuticals, Venture Capital Obsidian Therapeutics, cytoDRiVE (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 9, 2021 Category: Pharmaceuticals Source Type: news

Neuroglee Therapeutics Closes Series A Round to Advance Virtual Care and Digital Therapies for Alzheimer's Disease Treatment in the Home
$10 million funding round led by Openspace Ventures with participation from EDBI will fuel first-in-class virtual neurology clinics Neuroglee and Mayo Clinic to co-develop Neuroglee ConnectTM - a remote care management platform and virtual specialty car... Devices, Neurology, Venture Capital Neuroglee Therapeutics, digital therapeutics, Alzheimer's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 9, 2021 Category: Pharmaceuticals Source Type: news

ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience
NEW YORK and SAN DIEGO, Sept. 8, 2021 -- (Healthcare Sales & Marketing Network) -- ATP, a leader in life sciences venture capital, today announced the launch of Replicate Bioscience, a company pioneering ways to prevent drug resistance in cancer, and trea... Biopharmaceuticals, Venture Capital Replicate Bioscience, srRNA immunotherapies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2021 Category: Pharmaceuticals Source Type: news

Via Nova Therapeutics Announces $20 Million Series A Financing from Aditum Bio to Advance Four Antiviral Programs
OAKLAND, Calif., Sept. 7, 2021 -- (Healthcare Sales & Marketing Network) -- Via Nova Therapeutics announced today that it has closed its Series A financing and raised $20 million from Aditum Bio to advance the development of four preclinical antiviral pro... Biopharmaceuticals, Venture Capital Via Nova Therapeutics, influenza, adenovirus, rhinovirus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2021 Category: Pharmaceuticals Source Type: news

EnteroBiotix Raises over $21m in Series A Financing to Advance its Microbiome Drug Pipeline
GLASGOW, Scotland, Sept. 7, 2021 -- (Healthcare Sales & Marketing Network) -- EnteroBiotix, a biopharmaceutical company developing novel high-diversity microbial therapeutics that enhance the gut microbiome and target multiple indications, today announced... Biopharmaceuticals, Venture Capital EnteroBiotix, gut microbiome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2021 Category: Pharmaceuticals Source Type: news

Disc Medicine Announces $90 Million Series B Financing to Advance Portfolio of Clinical-Stage Therapies for Hematologic Diseases
Proceeds will be used to advance multiple programs in Disc's hematology pipeline into phase 2 development Financing led by OrbiMed and includes new investors Arix Bioscience, Janus Henderson Investors, 5AM Ventures, Rock Springs Capital and others CA... Biopharmaceuticals, Venture Capital Disc Medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 2, 2021 Category: Pharmaceuticals Source Type: news

This Startup Raised $50 Million To Help Therapists Build Virtual Private Practices —And Take Insurance
Alma, which began as subscription-based administrative software coupled with coworking spaces for therapists, pivoted during the Covid-19 pandemic to expand its tools for virtual therapy. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 31, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Enterprise Tech /enterprise-tech Coronavirus Editors' Pick editors-pick Source Type: news

With $60M, new acquisition, Peninsula company looks to deepen genome insights
Hoping to help more patients unlock the mysteries of the full package of genetic material within them, a Peninsula company doubled the amount of money it had raised and made its first acquisition. Genome Medical Inc. raised $60 million in a Series C round including new investors GV — the former Google Ventures — and the venture capital unit of biotech giant Amgen Inc. The South San Francisco company simultaneously bought Minneapolis-based GeneMatters, a telehealth genetic counseling a nd software… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 30, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

With $60M, new acquisition, Peninsula company looks to deepen genome insights
Hoping to help more patients unlock the mysteries of the full package of genetic material within them, a Peninsula company doubled the amount of money it had raised and made its first acquisition. Genome Medical Inc. raised $60 million in a Series C round including new investors GV — the former Google Ventures — and the venture capital unit of biotech giant Amgen Inc. The South San Francisco company simultaneously bought Minneapolis-based GeneMatters, a telehealth genetic counseling a nd software… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 30, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

The Funded: Trae Vassallo has left venture capital firm Defy to work for Apple
Vassallo said she actually turned down an opportunity to work with Apple's iPod team in 2003 when she chose to join her previous firm, Kleiner Perkins. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 30, 2021 Category: Pharmaceuticals Authors: Cromwell Schubarth Source Type: news

The Funded: Trae Vassallo has left venture capital firm Defy to work for Apple
Vassallo said she actually turned down an opportunity to work with Apple's iPod team in 2003 when she chose to join her previous firm, Kleiner Perkins. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 30, 2021 Category: Biotechnology Authors: Cromwell Schubarth Source Type: news

Laronde Attracts $440M in First External Financing to Further Advance Endless RNA(TM) Platform
Financing includes Laronde founder, Flagship Pioneering, as well as a wide group of public and private investors Capital infusion will enable the build out of Laronde's Endless RNA technology platform and large-scale development capabilities, advancing ... Biopharmaceuticals, Venture Capital Laronde, Endless RNA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 30, 2021 Category: Pharmaceuticals Source Type: news

NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
STATE COLLEGE, Pa., Aug. 30, 2021 -- (Healthcare Sales & Marketing Network) -- NeuExcell Therapeutics (www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $10+ million Series Pre-A financing round. The round ... Regenerative Medicine, Neurology, Venture Capital NeuExcell Therapeutics, gene therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 30, 2021 Category: Pharmaceuticals Source Type: news

The Funded: Trae Vassallo has left venture capital firm Defy to work for Apple
Vassallo said she actually turned down an opportunity to work with Apple's iPod team in 2003 when she chose to join her previous firm, Kleiner Perkins. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 27, 2021 Category: Pharmaceuticals Authors: Cromwell Schubarth Source Type: news

The Funded: Trae Vassallo has left venture capital firm Defy to work for Apple
Vassallo said she actually turned down an opportunity to work with Apple's iPod team in 2003 when she chose to join her previous firm, Kleiner Perkins. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 27, 2021 Category: Biotechnology Authors: Cromwell Schubarth Source Type: news

Osteocentric Technologies, Inc. Secures $30Mm in Growth Capital to Launch New Products at Osteocentric Trauma, LLC and Further Address the Systemic Problem of Implant Instability Across All Orthopedic Specialties and Dental Implants
With UnifiMI™, OsteoCentric Technologies is pioneering Mechanical Integration - a less invasive method to instantly secure an implant to bone utilizing a proprietary interlocking thread geometry. AUSTIN, Texas, Aug. 27, 2021 -- (Healthcare Sales & Marke... Devices, Orthopaedic, Dental, Venture Capital OsteoCentric Technologies, UnifiMI (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 27, 2021 Category: Pharmaceuticals Source Type: news

Sleep-Focused Supermoon Capital Raises $36 Million To Fund The ‘Night Market’
The sector-agnostic fund will invest in everything sleep-related from better sheets to diagnostics tools for sleep disorders. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 25, 2021 Category: Pharmaceuticals Authors: Rebecca Szkutak, Forbes Staff Tags: Venture Capital /venture-capital Innovation /innovation Science /science Healthcare /healthcare Editors' Pick editors-pick Source Type: news

MassBio: 40K new biopharma jobs predicted in next three years
Massachusetts-headquartered life sciences companies raised $4.3 billion in venture capital in just the first quarter of this year — nearly 75% of the venture capital raised in the entirety of 2020, which was already a record high at $5.8 billion. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 25, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news

MassBio: 40K new biopharma jobs predicted in next three years
Massachusetts-headquartered life sciences companies raised $4.3 billion in venture capital in just the first quarter of this year — nearly 75% of the venture capital raised in the entirety of 2020, which was already a record high at $5.8 billion. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 25, 2021 Category: Health Management Authors: Rowan Walrath Source Type: news

They Still Live in the Shadow of Theranos ’s Elizabeth Holmes
Female entrepreneurs said they were constantly compared to Ms. Holmes, the disgraced founder of Theranos, who faces trial soon. (Source: NYT Health)
Source: NYT Health - August 24, 2021 Category: Consumer Health News Authors: Erin Griffith Tags: Entrepreneurship Start-ups Tests (Medical) Women and Girls Drugs (Pharmaceuticals) Venture Capital Computers and the Internet Theranos Inc Holmes, Elizabeth (1984- ) Verge Genomics Discrimination Zhang, Alice Source Type: news

Elixiron Immunotherapeutics Announces Closing of $27 Million Series A-1 Financing Round to Progress Alzheimer's Disease and Vitiligo Clinical-Stage Assets
SAN FRANCISCO, Aug. 23, 2021 -- (Healthcare Sales & Marketing Network) -- Elixiron Immunotherapeutics, Inc., a privately held company developing therapeutics for cancer, neurological diseases and inflammatory disorders, has announced the closing of a Seri... Biopharmaceuticals, Venture Capital Elixiron Immunotherapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 23, 2021 Category: Pharmaceuticals Source Type: news

Health data analytics platform Covera Health lands $25M in Series C funding
Venture capital and private equity firm Insight Partners led the round with participation from existing investors including Equity Group Investments. (Source: mobihealthnews)
Source: mobihealthnews - August 23, 2021 Category: Information Technology Source Type: news

Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases
Series B financing led by Agent Capital Funding to advance novel NK and T cell modulator IMT-009 for the treatment of solid tumor and hematological cancers with an anticipated IND filing in 1H 2022 Expands leadership team with appointment of Chief Bu... Biopharmaceuticals, Venture Capital Immunitas Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 18, 2021 Category: Pharmaceuticals Source Type: news

SoftBank Backs Autism Intervention Startup Opya In Its $15.4 Million Series A
The startup uses a mix of in-person treatments and technology to help as many children under six with autism as possible. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 18, 2021 Category: Pharmaceuticals Authors: Rebecca Szkutak, Forbes Staff Tags: Venture Capital /venture-capital Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick Source Type: news

Fertility Startup Carrot Raises $75 Million In A Series C Round Led By Tiger Global
The company uses a B2B2C approach to improve accessibility to fertility benefits. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 17, 2021 Category: Pharmaceuticals Authors: Rebecca Szkutak, Forbes Staff Tags: Venture Capital /venture-capital Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick Source Type: news

Navrogen raises $3M in venture capital financing to advance cancer therapy platform
The four-year-old company also converted more than $3 million in notes into equity. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 16, 2021 Category: Biotechnology Authors: John George Source Type: news